UK Bans Puberty Blockers for Under-18s with Gender Dysphoria: A Comprehensive Summary
UK Bans Puberty Blockers for Under-18s with Gender Dysphoria: A Comprehensive Summary
Puberty blockers for under-18s with gender dysphoria have been banned indefinitely in the UK, following official advice from medical experts. The government said that the way the drugs had been used was a 'scandal', with children being prescribed the treatment after only one online consultation. The Commission on Human Medicines found that the current prescribing and care pathway for gender dysphoria presents an unacceptable safety risk for children and young people. A clinical trial into the use of puberty blockers will be established next year to establish a clear evidence base for the use of this medicine. The ban has been welcomed by some, but criticized by others as 'discrimination'.